BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24018353)

  • 1. Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells.
    Lee MC; Kuo YY; Chou WC; Hou HA; Hsiao M; Tien HF
    J Leukoc Biol; 2014 Jan; 95(1):105-15. PubMed ID: 24018353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin.
    Jegalian AG; Wu H
    J Biol Chem; 2002 Jan; 277(3):2345-52. PubMed ID: 11696536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms.
    Gao SM; Chen CQ; Wang LY; Hong LL; Wu JB; Dong PH; Yu FJ
    Exp Hematol; 2013 Mar; 41(3):261-70.e4. PubMed ID: 23111066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition.
    Lakshmikuttyamma A; Scott SA; DeCoteau JF; Geyer CR
    Oncogene; 2010 Jan; 29(4):576-88. PubMed ID: 19881540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells.
    Lai YS; Chen JY; Tsai HJ; Chen TY; Hung WC
    Blood Cancer J; 2015 May; 5(5):e313. PubMed ID: 25978433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between methylation of tumor suppressor gene SOCS1 and acute myeloid leukemia.
    Zhang XH; Yang L; Liu XJ; Zhan Y; Pan YX; Wang XZ; Luo JM
    Oncol Rep; 2018 Aug; 40(2):1008-1016. PubMed ID: 29916533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1.
    Saudemont A; Hamrouni A; Marchetti P; Liu J; Jouy N; Hetuin D; Colucci F; Quesnel B
    Cancer Res; 2007 May; 67(9):4491-8. PubMed ID: 17483365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IFN-gamma-dependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Krüppel-like factor-4, and it is dysregulated in psoriatic keratinocytes.
    Madonna S; Scarponi C; Sestito R; Pallotta S; Cavani A; Albanesi C
    J Immunol; 2010 Aug; 185(4):2467-81. PubMed ID: 20644166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML.
    Paul TA; Bies J; Small D; Wolff L
    Blood; 2010 Apr; 115(15):3098-108. PubMed ID: 20190193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT5A regulates DNMT3A in CD34(+)/CD38(-) AML cells.
    Takeuchi A; Nishioka C; Ikezoe T; Yang J; Yokoyama A
    Leuk Res; 2015 Aug; 39(8):897-905. PubMed ID: 26059451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic silences hepatic PDK4 expression through activation of histone H3K9 methylatransferase G9a.
    Zhang X; Wu J; Choiniere J; Yang Z; Huang Y; Bennett J; Wang L
    Toxicol Appl Pharmacol; 2016 Aug; 304():42-7. PubMed ID: 27217333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gfi1 coordinates epigenetic repression of p21Cip/WAF1 by recruitment of histone lysine methyltransferase G9a and histone deacetylase 1.
    Duan Z; Zarebski A; Montoya-Durango D; Grimes HL; Horwitz M
    Mol Cell Biol; 2005 Dec; 25(23):10338-51. PubMed ID: 16287849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia.
    Chen CY; Tsay W; Tang JL; Shen HL; Lin SW; Huang SY; Yao M; Chen YC; Shen MC; Wang CH; Tien HF
    Genes Chromosomes Cancer; 2003 Jul; 37(3):300-5. PubMed ID: 12759928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
    Chu Y; Chen Y; Guo H; Li M; Wang B; Shi D; Cheng X; Guan J; Wang X; Xue C; Cheng T; Shi J; Yuan W
    Oncogene; 2020 Dec; 39(50):7239-7252. PubMed ID: 33037410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression.
    Cattaneo F; Nucifora G
    J Cell Biochem; 2008 Oct; 105(2):344-52. PubMed ID: 18655152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin A.
    Tran HT; Kim HN; Lee IK; Nguyen-Pham TN; Ahn JS; Kim YK; Lee JJ; Park KS; Kook H; Kim HJ
    J Korean Med Sci; 2013 Feb; 28(2):237-46. PubMed ID: 23400519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
    Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
    J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma.
    Cai L; Ma X; Huang Y; Zou Y; Chen X
    Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
    Capello D; Deambrogi C; Rossi D; Lischetti T; Piranda D; Cerri M; Spina V; Rasi S; Gaidano G; Lunghi M
    Br J Haematol; 2008 May; 141(4):504-11. PubMed ID: 18318760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of GFI-1 Gene is associated with Panobinostat-resistance in acute myeloid leukemia through influencing the level of HO-1.
    Cheng B; Tang S; Zhe N; Ma D; Yu K; Wei D; Zhou Z; Lu T; Wang J; Fang Q
    Biomed Pharmacother; 2018 Apr; 100():509-520. PubMed ID: 29494986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.